{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:01:03Z","timestamp":1793815263731,"version":"4.6.1"},"reference-count":34,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2024,2,1]]},"abstract":"<jats:sec>\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Cell therapy is a promising treatment approach for stroke and other diseases. However, it is unknown whether MultiStem (HLCM051), a bone marrow\u2013derived, allogeneic, multipotent adult progenitor cell product, has the potential to treat ischemic stroke.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess the efficacy and safety of MultiStem when administered within 18 to 36 hours of ischemic stroke onset.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>The Treatment Evaluation of Acute Stroke Using Regenerative Cells (TREASURE) multicenter, double-blind, parallel-group, placebo-controlled phase 2\/3 randomized clinical trial was conducted at 44 academic and clinical centers in Japan between November 15, 2017, and March 29, 2022. Inclusion criteria were age 20 years or older, presence of acute ischemic stroke (National Institutes of Health Stroke Scale [NIHSS] score of 8-20 at baseline), confirmed acute infarction involving the cerebral cortex and measuring more than 2 cm on the major axis (determined with diffusion-weighted magnetic resonance imaging), and a modified Rankin Scale (mRS) score of 0 or 1 before stroke onset. Data analysis was performed between May 9 and August 15, 2022.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Exposure<\/jats:title>\n                    <jats:p>Patients were randomly assigned to either intravenous MultiStem in 1 single unit of 1.2 billion cells or intravenous placebo within 18 to 36 hours of ischemic stroke onset.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The primary end points were safety and excellent outcome at day 90, measured as a composite of a modified Rankin Scale (mRS) score of 1 or less, a NIHSS score of 1 or less, and a Barthel index score of 95 or greater. The secondary end points were excellent outcome at day 365, mRS score distribution at days 90 and 365, and mRS score of 0 to 1 and 0 to 2 at day 90. Statistical analysis of efficacy was performed using the Cochran-Mantel-Haenszel test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      This study included 206 patients (104 received MultiStem and 102 received placebo). Their mean age was 76.5 (range, 35-95) years, and more than half of patients were men (112 [54.4%]). There were no between-group differences in primary and secondary end points. The proportion of excellent outcomes at day 90 did not differ significantly between the MultiStem and placebo groups (12 [11.5%] vs 10 [9.8%],\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.90; adjusted risk difference, 0.5% [95% CI, \u22127.3% to 8.3%]). The frequency of adverse events was similar between treatment groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this randomized clinical trial, intravenous administration of allogeneic cell therapy within 18 to 36 hours of ischemic stroke onset was safe but did not improve short-term outcomes. Further research is needed to determine whether MultiStem therapy for ischemic stroke has a beneficial effect in patients who meet specific criteria, as indicated by the exploratory analyses in this study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov Identifier:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/study\/NCT02961504\">NCT02961504<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamaneurol.2023.5200","type":"journal-article","created":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T11:02:26Z","timestamp":1705402946000},"page":"154","source":"Crossref","is-referenced-by-count":85,"title":["Allogeneic Stem Cell Therapy for Acute Ischemic Stroke"],"prefix":"10.1001","volume":"81","author":[{"given":"Kiyohiro","family":"Houkin","sequence":"first","affiliation":[{"name":"Hokkaido University, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiya","family":"Osanai","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hokkaido University, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Uchiyama","sequence":"additional","affiliation":[{"name":"Clinical Research Center for Medicine, International University of Health and Welfare, Tokyo, Japan"},{"name":"Center for Brain and Cerebral Vessels, Sanno Medical Center, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Minematsu","sequence":"additional","affiliation":[{"name":"Iseikai International General Hospital, Osaka City, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Taguchi","sequence":"additional","affiliation":[{"name":"Department of Regenerative Medicine Research, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhiko","family":"Maruichi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Kashiwaba Neurosurgical Hospital, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimasa","family":"Niiya","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Otaru General Hospital, Otaru, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuyuki","family":"Asaoka","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Teine Keijinkai Medical Center, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Kuga","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Ohnishi Neurological Center, Akashi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsumi","family":"Takizawa","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Japanese Red Cross Asahikawa Hospital, Asahikawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Haraguchi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hakodate Shintoshi Hospital, Hakodate, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Yoshimura","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hyogo Medical University, Nishinomiya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumi","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nippon Medical School Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Tokunaga","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Okayama City Hospital, Okayama City, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuo","family":"Aoyama","sequence":"additional","affiliation":[{"name":"Department of Neurology, Shimane Prefectural Central Hospital, Izumo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fusao","family":"Ikawa","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Shimane Prefectural Central Hospital, Izumo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikanori","family":"Inenaga","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Seirei Hamamatsu General Hospital, Hamamatsu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Saga University, Nabeshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Tominaga","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and Neuroendovascular Therapy, Hiroshima Prefectural Hospital, Hiroshima City, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Neurology and Stroke, Saitama Medical University International Medical Center, Hidaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohsuke","family":"Kudo","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Imaging, Hokkaido University, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Fujimura","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hokkaido University, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taku","family":"Sugiyama","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hokkaido University, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hokkaido University, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahito","family":"Kawabori","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hokkaido University, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Hess","sequence":"additional","affiliation":[{"name":"Department of Neurology, Medical College of Georgia, Augusta University, Augusta"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean I.","family":"Savitz","sequence":"additional","affiliation":[{"name":"Department of Neurology Institute for Stroke and Cerebrovascular Disease, UTHealth, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruyuki","family":"Hirano","sequence":"additional","affiliation":[{"name":"Department of Stroke and Cerebrovascular Medicine, Kyorin University, Mitaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"TREASURE Study Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyohiro","family":"Houkin","sequence":"additional","affiliation":[{"name":"for the TREASURE Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiya","family":"Osanai","sequence":"additional","affiliation":[{"name":"for the TREASURE Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhiko","family":"Maruichi","sequence":"additional","affiliation":[{"name":"for the TREASURE Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimasa","family":"Niiya","sequence":"additional","affiliation":[{"name":"for the TREASURE Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuyuki","family":"Asaoka","sequence":"additional","affiliation":[{"name":"for the TREASURE Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsumi","family":"Takizawa","sequence":"additional","affiliation":[{"name":"for the TREASURE Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouichi","family":"Haraguchi","sequence":"additional","affiliation":[{"name":"for the TREASURE Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rokuya","family":"Tanikawa","sequence":"additional","affiliation":[{"name":"for the TREASURE Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Tempaku","sequence":"additional","affiliation":[{"name":"for the TREASURE Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Shimoda","sequence":"additional","affiliation":[{"name":"for the TREASURE Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Isobe","sequence":"additional","affiliation":[{"name":"for the TREASURE Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Kamiyama","sequence":"additional","affiliation":[{"name":"for the TREASURE Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Ohtaki","sequence":"additional","affiliation":[{"name":"for the TREASURE Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihito","family":"Shimamura","sequence":"additional","affiliation":[{"name":"for the TREASURE Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junta","family":"Moroi","sequence":"additional","affiliation":[{"name":"for the TREASURE Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiki","family":"Marushima","sequence":"additional","affiliation":[{"name":"for the TREASURE Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Takahashi","sequence":"additional","affiliation":[{"name":"for the TREASURE Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Urabe","sequence":"additional","affiliation":[{"name":"for the TREASURE Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruyuki","family":"Hirano","sequence":"additional","affiliation":[{"name":"for the TREASURE Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumi","family":"Kimura","sequence":"additional","affiliation":[{"name":"for the TREASURE Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Kitagawa","sequence":"additional","affiliation":[{"name":"for the TREASURE Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetoshi","family":"Kasuya","sequence":"additional","affiliation":[{"name":"for the TREASURE Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikane","family":"Izawa","sequence":"additional","affiliation":[{"name":"for the TREASURE Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Iguchi","sequence":"additional","affiliation":[{"name":"for the TREASURE Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Oki","sequence":"additional","affiliation":[{"name":"for the TREASURE Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Kato","sequence":"additional","affiliation":[{"name":"for the TREASURE Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihisa","family":"Yamano","sequence":"additional","affiliation":[{"name":"for the TREASURE Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Kuroda","sequence":"additional","affiliation":[{"name":"for the TREASURE Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Sato","sequence":"additional","affiliation":[{"name":"for the TREASURE Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikanori","family":"Inenaga","sequence":"additional","affiliation":[{"name":"for the TREASURE Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keizo","family":"Yasui","sequence":"additional","affiliation":[{"name":"for the TREASURE Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Toyoda","sequence":"additional","affiliation":[{"name":"for the TREASURE Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Yoshimura","sequence":"additional","affiliation":[{"name":"for the TREASURE Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Sakai","sequence":"additional","affiliation":[{"name":"for the TREASURE Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Kuga","sequence":"additional","affiliation":[{"name":"for the TREASURE Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuo","family":"Aoyama","sequence":"additional","affiliation":[{"name":"for the TREASURE Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fusao","family":"Ikawa","sequence":"additional","affiliation":[{"name":"for the TREASURE Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Tokunaga","sequence":"additional","affiliation":[{"name":"for the TREASURE Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Tominaga","sequence":"additional","affiliation":[{"name":"for the TREASURE Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Takagi","sequence":"additional","affiliation":[{"name":"for the TREASURE Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Yasaka","sequence":"additional","affiliation":[{"name":"for the TREASURE Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Abe","sequence":"additional","affiliation":[{"name":"for the TREASURE Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Matsuo","sequence":"additional","affiliation":[{"name":"for the TREASURE Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiro","family":"Yonehara","sequence":"additional","affiliation":[{"name":"for the TREASURE Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Terasaki","sequence":"additional","affiliation":[{"name":"for the TREASURE Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Matsuoka","sequence":"additional","affiliation":[{"name":"for the TREASURE Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"noi230096r1","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1177\/17474930211065917","article-title":"World Stroke Organization (WSO): global stroke fact sheet 2022.","volume":"17","author":"Feigin","year":"2022","journal-title":"Int J Stroke"},{"issue":"3","key":"noi230096r2","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1161\/STR.0b013e318284056a","article-title":"Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association.","volume":"44","author":"Jauch","year":"2013","journal-title":"Stroke"},{"issue":"1","key":"noi230096r3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1177\/2396987319832140","article-title":"European Stroke Organisation (ESO)\u2014European Society for Minimally Invasive Neurological Therapy (ESMINT) guidelines on mechanical thrombectomy in acute ischaemic stroke endorsed by Stroke Alliance for Europe (SAFE).","volume":"4","author":"Turc","year":"2019","journal-title":"Eur Stroke J"},{"issue":"10029","key":"noi230096r4","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/S0140-6736(16)00163-X","article-title":"Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials.","volume":"387","author":"Goyal","year":"2016","journal-title":"Lancet"},{"issue":"5","key":"noi230096r5","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1161\/STROKEAHA.118.018287","article-title":"Intravenous cellular therapies for acute ischemic stroke.","volume":"49","author":"Mays","year":"2018","journal-title":"Stroke"},{"issue":"2","key":"noi230096r6","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1159\/000086518","article-title":"Neurotransplantation of fetal porcine cells in patients with basal ganglia infarcts: a preliminary safety and feasibility study.","volume":"20","author":"Savitz","year":"2005","journal-title":"Cerebrovasc Dis"},{"issue":"16","key":"noi230096r7","doi-asserted-by":"publisher","first-page":"9094","DOI":"10.1073\/pnas.2000690117","article-title":"Activity in grafted human iPS cell-derived cortical neurons integrated in stroke-injured rat brain regulates motor behavior.","volume":"117","author":"Palma-Tortosa","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"noi230096r8","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1161\/STROKEAHA.116.012701","article-title":"Systematic review and meta-analysis of bone marrow-derived mononuclear cells in animal models of ischemic stroke.","volume":"47","author":"Vahidy","year":"2016","journal-title":"Stroke"},{"issue":"41","key":"noi230096r9","doi-asserted-by":"publisher","first-page":"10529","DOI":"10.1523\/JNEUROSCI.1643-16.2016","article-title":"Neural stem cell transplantation induces stroke recovery by upregulating glutamate transporter GLT-1 in astrocytes.","volume":"36","author":"Bacigaluppi","year":"2016","journal-title":"J Neurosci"},{"key":"noi230096r10","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.662636","article-title":"Neuronal replacement in stem cell therapy for stroke: filling the gap.","volume":"9","author":"Palma-Tortosa","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"noi230096r11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/ana.v70.1","article-title":"Intravenous autologous bone marrow mononuclear cells for ischemic stroke.","volume":"70","author":"Savitz","year":"2011","journal-title":"Ann Neurol"},{"issue":"8","key":"noi230096r12","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1161\/STROKEAHA.112.659409","article-title":"Intra-arterial bone marrow mononuclear cells in ischemic stroke: a pilot clinical trial.","volume":"43","author":"Moniche","year":"2012","journal-title":"Stroke"},{"key":"noi230096r13","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.3727\/096368914X684961","article-title":"A two-year follow-up study of cotransplantation with neural stem\/progenitor cells and mesenchymal stromal cells in ischemic stroke patients.","volume":"23","author":"Qiao","year":"2014","journal-title":"Cell Transplant"},{"issue":"10","key":"noi230096r14","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1161\/STROKEAHA.119.026318","article-title":"Phase I\/II study of safety and preliminary efficacy of intravenous allogeneic mesenchymal stem cells in chronic stroke.","volume":"50","author":"Levy","year":"2019","journal-title":"Stroke"},{"issue":"6","key":"noi230096r15","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1002\/ana.v57:6","article-title":"Autologous mesenchymal stem cell transplantation in stroke patients.","volume":"57","author":"Bang","year":"2005","journal-title":"Ann Neurol"},{"issue":"6","key":"noi230096r16","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1002\/stem.430","article-title":"A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke.","volume":"28","author":"Lee","year":"2010","journal-title":"Stem Cells"},{"issue":"5","key":"noi230096r17","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1007\/s12975-020-00787-z","article-title":"Autologous mesenchymal stem cells improve motor recovery in subacute ischemic stroke: a randomized clinical trial.","volume":"11","author":"Jaillard","year":"2020","journal-title":"Transl Stroke Res"},{"issue":"7","key":"noi230096r18","doi-asserted-by":"publisher","first-page":"e1012","DOI":"10.1212\/WNL.0000000000011440","article-title":"Efficacy and safety of intravenous mesenchymal stem cells for ischemic stroke.","volume":"96","author":"Chung","year":"2021","journal-title":"Neurology"},{"issue":"5","key":"noi230096r19","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/S1474-4422(17)30046-7","article-title":"Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial.","volume":"16","author":"Hess","year":"2017","journal-title":"Lancet Neurol"},{"issue":"7","key":"noi230096r20","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.bbmt.2009.12.005","article-title":"Regenerative stromal cell therapy in allogeneic hematopoietic stem cell transplantation: current impact and future directions.","volume":"16","author":"Auletta","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"noi230096r21","doi-asserted-by":"publisher","DOI":"10.1177\/09636897221083863","article-title":"Final results of allogeneic adipose tissue-derived mesenchymal stem cells in acute ischemic stroke (AMASCIS): a phase II, randomized, double-blind, placebo-controlled, single-center, pilot clinical trial.","volume":"31","author":"de Celis-Ruiz","year":"2022","journal-title":"Cell Transplant"},{"issue":"4","key":"noi230096r22","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1177\/1747493017743057","article-title":"Treatment evaluation of acute stroke for using in regenerative cell elements (TREASURE) trial: rationale and design.","volume":"13","author":"Osanai","year":"2018","journal-title":"Int J Stroke"},{"issue":"1","key":"noi230096r23","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1001\/jamaneurol.2021.4346","article-title":"Twenty-year change in severity and outcome of ischemic and hemorrhagic strokes.","volume":"79","author":"Toyoda","year":"2022","journal-title":"JAMA Neurol"},{"issue":"1","key":"noi230096r24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41582-022-00736-4","article-title":"Cell-based therapies for neurological disorders\u2014the bioreactor hypothesis.","volume":"19","author":"Savitz","year":"2023","journal-title":"Nat Rev Neurol"},{"issue":"9","key":"noi230096r25","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1001\/jamaneurol.2022.1988","article-title":"Time for a new perspective on intracerebral hemorrhage.","volume":"79","author":"Selim","year":"2022","journal-title":"JAMA Neurol"},{"issue":"7","key":"noi230096r26","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1002\/sctm.20-0369","article-title":"Longitudinal neuroimaging evaluation of the corticospinal tract in patients with stroke treated with autologous bone marrow cells.","volume":"10","author":"Haque","year":"2021","journal-title":"Stem Cells Transl Med"},{"key":"noi230096r27","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3389\/fneur.2019.00235","article-title":"Combined adipose tissue-derived mesenchymal stem cell therapy and rehabilitation in experimental stroke.","volume":"10","author":"Mu","year":"2019","journal-title":"Front Neurol"},{"issue":"14","key":"noi230096r28","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1056\/NEJMoa2118191","article-title":"Endovascular therapy for acute stroke with a large ischemic region.","volume":"386","author":"Yoshimura","year":"2022","journal-title":"N Engl J Med"},{"issue":"8","key":"noi230096r29","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1097\/01.TP.0000082540.43730.80","article-title":"Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells.","volume":"76","author":"Rasmusson","year":"2003","journal-title":"Transplantation"},{"issue":"15","key":"noi230096r30","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1056\/NEJMoa2207576","article-title":"Trial of thrombectomy 6 to 24 hours after stroke due to basilar-artery occlusion.","volume":"387","author":"Jovin","year":"2022","journal-title":"N Engl J Med"},{"issue":"15","key":"noi230096r31","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1056\/NEJMoa2206317","article-title":"Trial of endovascular treatment of acute basilar-artery occlusion.","volume":"387","author":"Tao","year":"2022","journal-title":"N Engl J Med"},{"issue":"2","key":"noi230096r32","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S1474-4422(19)30395-3","article-title":"Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial.","volume":"19","author":"Liu","year":"2020","journal-title":"Lancet Neurol"},{"issue":"20","key":"noi230096r33","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1056\/NEJMoa2030297","article-title":"Endovascular therapy for stroke due to basilar-artery occlusion.","volume":"384","author":"Langezaal","year":"2021","journal-title":"N Engl J Med"},{"issue":"9","key":"noi230096r34","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1111\/ene.v29.9","article-title":"Endovascular therapy versus no endovascular therapy in patients receiving best medical management for acute isolated occlusion of the posterior cerebral artery: a systematic review and meta-analysis.","volume":"29","author":"Berberich","year":"2022","journal-title":"Eur J Neurol"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2813591\/jamaneurology_houkin_2024_oi_230096_1707344377.15399.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T11:02:00Z","timestamp":1707735720000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2813591"}},"subtitle":["The Phase 2\/3 TREASURE Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2024,2,1]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2023.5200","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,1]]}}}